Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
1.500
-0.040 (-2.60%)
At close: Aug 27, 2026, 4:00 PM EDT
1.500
0.00 (0.00%)
After-hours: Aug 27, 2026, 4:10 PM EDT

Curis Revenue

Curis had revenue of $4.31M in the twelve months ending June 30, 2026, down -62.17% year-over-year. In the year 2025, Curis had annual revenue of $9.44M, down -13.43%.

Revenue (ttm)
$4.31M
Revenue Growth
-62.17%
P/S Ratio
0.71
Revenue / Employee
$179,750
Employees
24
Market Cap
3.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.44M-1.47M-13.43%
Dec 31, 202410.91M885.00K8.83%
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 201810.43M530.00K5.35%
Dec 31, 20179.90M2.37M31.50%
Dec 31, 20167.53M-351.00K-4.46%
Dec 31, 20157.88M-1.97M-19.96%
Dec 31, 20149.84M-5.16M-34.39%
Dec 31, 201315.00M-1.97M-11.61%
Dec 31, 201216.97M2.21M14.97%
Dec 31, 201114.76M-1.24M-7.73%
Dec 31, 201016.00M7.41M86.26%
Dec 31, 20098.59M223.32K2.67%
Dec 31, 20088.37M-8.02M-48.95%
Dec 31, 200716.39M1.45M9.73%
Dec 31, 200614.94M8.93M148.83%
Dec 31, 20056.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
60 Degrees Pharmaceuticals1.21M
SciSparc856.00K
Jupiter Neurosciences64.69K
Silo Pharma54.08K
Valion Bio-86.00K
Revenue Rankings